Gene expression atlas captures where ovulation can go awry
An interdisciplinary collaboration has used a cutting-edge form of RNA tagging to map the gene expression that occurs during follicle maturation and ovulation in mice.
Jan 23, 2024
0
71
An interdisciplinary collaboration has used a cutting-edge form of RNA tagging to map the gene expression that occurs during follicle maturation and ovulation in mice.
Jan 23, 2024
0
71
Resistance to therapies is one of the obstacles to overcome in cancer treatments. Understanding the mechanisms of this resistance is essential to design strategies that favor tumor cell death. A study led by the Protein Kinases ...
Dec 14, 2023
0
14
Cancer patients who receive radiation during their treatment—and about half do—may face a lesser-known challenge: bone loss. The vital treatment for cancers of the head and neck, breast, cervix, prostate, and even eyes ...
Dec 6, 2023
0
69
A team at the Medical University of South Carolina and Cincinnati Children's has developed a sophisticated model for studying the diseased colon that could lead to the development of personalized treatments for colon-related ...
Nov 20, 2023
0
32
Nanoplastics interact with a particular protein that is naturally found in the brain, creating changes linked to Parkinson's disease and some types of dementia.
Nov 17, 2023
0
99
Investigators from the UCLA Health Jonsson Comprehensive Cancer Center have developed an artificial intelligence (AI) model based on epigenetic factors that is able to predict patient outcomes successfully across multiple ...
Nov 16, 2023
0
18
Researchers at Karolinska Institutet and SciLifeLab in Sweden have combined artificial intelligence (AI) techniques used in satellite imaging and community ecology to interpret large amounts of data from tumor tissue. The ...
Nov 13, 2023
0
17
Cancer cells are often a mess of mutations. About 20% to 25% of cancers involve mutations in a complex of molecules called SWI/SNF. Yet drugs designed to block SWI/SNF activity haven't always worked as expected. Researchers ...
Nov 3, 2023
0
42
Researchers at MUSC Hollings Cancer Center believe that some drugs already approved by the FDA or currently in clinical trials could be repurposed for certain breast cancer patients whose cancer has become resistant to standard ...
Nov 2, 2023
0
42
Cancer cells are notorious for rapidly changing their phenotype, driving within-host spread and evading treatment. Scientists in Plön have used a mathematical model to understand the role of a signal used by cancer cells ...
Oct 26, 2023
0
20